Javier San Martín

11.9k total citations · 6 hit papers
103 papers, 7.9k citations indexed

About

Javier San Martín is a scholar working on Oncology, General Social Sciences and Philosophy. According to data from OpenAlex, Javier San Martín has authored 103 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 24 papers in General Social Sciences and 19 papers in Philosophy. Recurrent topics in Javier San Martín's work include Philosophical Thought and Analysis (22 papers), Bone health and treatments (20 papers) and Bone health and osteoporosis research (16 papers). Javier San Martín is often cited by papers focused on Philosophical Thought and Analysis (22 papers), Bone health and treatments (20 papers) and Bone health and osteoporosis research (16 papers). Javier San Martín collaborates with scholars based in United States, Canada and Spain. Javier San Martín's co-authors include Michael R. McClung, Suresh Siddhanti, Cesar Libanati, Michael A. Bolognese, Henry G. Bone, Steven R. Cummings, Ian R. Reid, José Zanchetta, Matt Austin and Ethel S. Siris and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Javier San Martín

81 papers receiving 7.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

2009 2.4k citations Steven R. Cummings, Javier San Martín et al. New England Journal of Medicine profile →
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

2012 495 citations David L. Lacey, William J. Boyle et al. Nature Reviews Drug Discovery profile →
Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

2011 433 citations Henry G. Bone, David L. Kendler et al. profile →
Burosumab Therapy in Children with X-Linked Hypophosphatemia

2018 321 citations Javier San Martín et al. New England Journal of Medicine profile →
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

2024 103 citations Daniel Gaudet, Robert A. Hegele et al. New England Journal of Medicine profile →
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia

2024 90 citations Daniel Gaudet, Dénes Páll et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Javier San Martín United States	32	4.9k	4.8k	3.5k	1.3k	1.1k	103	7.9k
Silvano Adami Italy	46	4.1k 0.8×	4.9k 1.0×	2.9k 0.8×	1.3k 1.0×	605 0.6×	142	8.5k
Suzanne M. Jan de Beur United States	25	1.7k 0.3×	2.6k 0.5×	1.5k 0.4×	1.4k 1.1×	1.5k 1.5×	52	5.7k
Suresh Siddhanti United States	24	2.9k 0.6×	3.2k 0.7×	2.3k 0.7×	660 0.5×	302 0.3×	54	4.7k
Antonio Lombardi United States	20	3.5k 0.7×	4.0k 0.8×	1.6k 0.5×	810 0.6×	166 0.2×	36	5.1k
Fernando Marín Spain	30	1.6k 0.3×	2.5k 0.5×	1.2k 0.3×	818 0.7×	192 0.2×	82	3.5k
Catherine Van Poznak United States	39	5.2k 1.1×	1.7k 0.4×	1.3k 0.4×	764 0.6×	63 0.1×	150	7.3k
Peyman Hadji Germany	37	3.9k 0.8×	1.7k 0.3×	1.1k 0.3×	759 0.6×	77 0.1×	167	5.8k
Agnès Linglart France	41	987 0.2×	475 0.1×	2.1k 0.6×	717 0.6×	2.0k 1.9×	243	6.0k
Katia Tonkin Canada	33	4.4k 0.9×	623 0.1×	1.8k 0.5×	700 0.6×	39 0.0×	86	6.5k
R. Bergström Sweden	43	1.9k 0.4×	337 0.1×	787 0.2×	974 0.8×	424 0.4×	110	5.3k

Countries citing papers authored by Javier San Martín

Since Specialization

Citations

This map shows the geographic impact of Javier San Martín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier San Martín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier San Martín more than expected).

Fields of papers citing papers by Javier San Martín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier San Martín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier San Martín. The network helps show where Javier San Martín may publish in the future.

Co-authorship network of co-authors of Javier San Martín

This figure shows the co-authorship network connecting the top 25 collaborators of Javier San Martín. A scholar is included among the top collaborators of Javier San Martín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier San Martín. Javier San Martín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vasas, Szilárd, Masoud Azizad, Peter Clifton, et al.. (2024). †Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results. Journal of clinical lipidology. 18(4). e560–e560.

Páll, Dénes, Gerald F. Watts, Stephen C. Nicholls, et al.. (2024). †Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results. Journal of clinical lipidology. 18(4). e564–e564. 1 indexed citations

Strnad, Pavel, Mattias Mandorfer, Gourab Choudhury, et al.. (2022). Fazirsiran for Liver Disease Associated with Alpha ₁ -Antitrypsin Deficiency. New England Journal of Medicine. 387(6). 514–524. 65 indexed citations

Clifton, Peter, David Sullivan, John E. Baker, et al.. (2020). Abstract 12594: Pharmacodynamic Effect of ARO-APOC3, an Investigational Hepatocyte-targeted RNA Interference Therapeutic Targeting Apolipoprotein C3, in Patients With Hypertriglyceridemia and Multifactorial Chylomicronemia. Circulation. 142(Suppl_3). 14 indexed citations

Martín, Javier San. (2020). La Relación De La Fenomenología Y La Psicología Como Un Motor De La Fenomenología Trascendental.. 1(2). 206–231. 1 indexed citations

Martín, Javier San. (2013). Antropología filosófica I: de la antropología científica a la filosófica. Dialnet (Universidad de la Rioja). 60(3). 9N–9N.

Martín, Javier San, et al.. (2013). La fenomenología de Ortega y Gasset. Revista de hispanismo filosófico. 305. 1 indexed citations

Martín, Javier San. (2013). LA VIDA RADICAL COMO CONCIENCIA TRASCENDENTAL. Repositorio Institucional Académico , Sistema de Bibliotecas Universidad Andrés Bello (UNAB) (Universidad Andrés Bello (UNAB)). 1 indexed citations

Lacey, David L., William J. Boyle, W. Scott Simonet, et al.. (2012). Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab. Nature Reviews Drug Discovery. 11(5). 401–419. 495 indexed citations breakdown →

10.

Martín, Javier San. (2010). Tres análisis fenomenológicos orteguianos. 7–26.

11.

Martín, Javier San, et al.. (2010). Las dimensiones de la vida humana: Ortega, Zubiri, Marías y Laín Entralgo. 1 indexed citations

12.

Martín, Javier San. (2010). El contenido del cuerpo. 0(2). 169–169. 7 indexed citations

13.

Kendler, David L., Christian Roux, Claude Laurent Benhamou, et al.. (2009). Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. Journal of Bone and Mineral Research. 25(1). 72–81. 322 indexed citations

14.

Cummings, Steven R., Javier San Martín, Michael R. McClung, et al.. (2009). Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis. Obstetrical & Gynecological Survey. 64(12). 805–807. 41 indexed citations

15.

Brown, Jacques P., Richard L. Prince, Chad Deal, et al.. (2008). Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial. Journal of Bone and Mineral Research. 24(1). 153–161. 436 indexed citations

16.

Martín, Javier San. (1998). Fenomenología y cultura en Ortega: ensayos de interpretación. Virtual Defense Library (Ministerio de Defensa). 2 indexed citations

17.

Martín, Javier San. (1993). Sobre el concepto de mundo de la vida. Espacio Tiempo y Forma Serie I Prehistoria y Arqueología.

18.

Martín, Javier San. (1992). El mundo como apriori. Notas sobre el concepto de mundo en los proyectos de Fink para las Meditaciones Cartesianas.. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Martín, Javier San. (1992). Ortega y Husserl: a vueltas con una relación polémica. Revista de occidente. 107–127. 1 indexed citations

20.

Martín, Javier San. (1992). Ética, antropología y filosofía de la historia. Las Lecciones de Husserl de Introducción a la ética del Semestre de Verano de 1920. Isegoría. 43–77. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact